a Department of Surgery , Lorestan University of Medical Sciences , Khorramabad , Iran.
b Department of Medical Biotechnology , School of Advanced Technologies in Medicine, Tehran University of Medical sciences , Tehran , Iran.
Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):26-32. doi: 10.1080/21691401.2017.1304407. Epub 2017 Mar 29.
The impairment of ulcer wound healing in diabetic patients is a vital clinical problem affecting millions of patients. Several clinical and basic science studies have demonstrated that stem cell therapy, to be effective in healing diabetic ulcer. Furthermore, these ulcer wounds may be healed from molecular maneuvering of growth factors to improve microcirculation within the ulcer wound. In addition, ulcer wound dressings may be employed as medicated systems, through the delivery of drugs, growth factors, peptides and stem cells. These dressing materials can include natural, modified and synthetic polymers, as well as their mixtures or combinations. This review paper will give a summary of some of the recent advances on the application of stem cells, biomaterials and growth factors in the treatment of diabetic ulcer wound.
糖尿病患者的溃疡伤口愈合受损是一个重大的临床问题,影响着数以百万计的患者。一些临床和基础科学研究表明,干细胞疗法在治疗糖尿病性溃疡方面是有效的。此外,这些溃疡伤口可以通过分子操作生长因子来改善溃疡伤口内的微循环来愈合。此外,溃疡伤口敷料可以作为药物输送系统,通过输送药物、生长因子、肽和干细胞来使用。这些敷料材料可以包括天然的、改性的和合成的聚合物,以及它们的混合物或组合。本文综述了近年来在应用干细胞、生物材料和生长因子治疗糖尿病性溃疡方面的一些进展。